Under pressure, FDA to hold public meeting on off-label use
May 06, 2015 at 20:07 PM EDT
WASHINGTON, May 6 (Reuters) - The U.S. Food and Drug Administration will hold a public meeting this summer to address drug company concern that restrictions on what they can say about off-label use of drugs violate their first amendment right to free speech.